Roquefort Therapeutics plc (LON: ROQ)
London
· Delayed Price · Currency is GBP · Price in GBX4.070
+0.120 (3.04%)
Dec 23, 2024, 2:26 PM BST
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 5.10 million as of December 23, 2024. Its market cap has decreased by -43.57% in one year.
Market Cap
5.10M
Enterprise Value
5.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.07
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has increased from 2.19M to 5.10M, an increase of 133.26%. That is a compound annual growth rate of 25.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 5.10M | -45.52% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 159.00B |
| GSK plc | 53.86B |
| Haleon plc | 34.50B |
| Smith & Nephew plc | 8.48B |
| ConvaTec Group PLC | 4.52B |
| Hikma Pharmaceuticals PLC | 4.33B |
| Oxford Nanopore Technologies plc | 1.37B |
| Animalcare Group plc | 143.09M |